Reduced nNOS expression induced by repeated nicotine treatment in μ-opioid receptor knockout mice

Neuroscience Letters

Volumn 380, Issue 1-2, 2005, Pages 70-74

  Yoo, Ji Hoon ^a   Cho, Jae Han ^a   Lee, Seok Yong ^a   Loh, Horace H ^b   Ho, Ing K ^c   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Immunohistochemistry; Knockout mice; Nicotine; Nnos; Sensitization; Opioid receptors

Indexed keywords

MU OPIATE RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 18044368669     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.01.001     Document Type: Article

References (26)

1. M.L. Adams, and T.J. Cicero Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal Eur. J. Pharmacol. 345 1998 R1 R2
2. F. Berrendero, B.L. Kieffer, and R. Maldonado Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice J. Neurosci. 22 2002 10935 10940
3. D.S. Bredt, and S.H. Snyder Nitric oxide, a novel neuronal messenger Neuron 8 1992 3 11
4. J. Bruhwyler, E. Chleide, J.F. Liegeois, and F. Carreer Nitric oxide: a new messenger in the brain Neurosci. Biobehav. Rev. 17 1993 373 384
5. B. Conte-Devolx, C. Oliver, P. Giraud, P. Gillioz, E. Castanas, J.C. Lissitzky, F. Boudouresque, and Y. Millet Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat Life Sci. 28 1981 1067 1073
6. W.A. Corrigall, S. Herling, and K.M. Coen Evidence for opioid mechanisms in the behavioral effects of nicotine Psychopharmacology (Berl.) 96 1988 29 35
7. U. Forstermann, H.H.H.W. Schmidt, J.S. Pollock, H. Sheng, J.A. Mitchell, T.D. Warner, M. Nakane, and F. Murad Isoforms of nitric oxide synthase characterization and purification from different cell types Biochem. Pharmacol. 42 1991 1849 1857
8. G.L. Gerdeman, J.G. Partridge, C.R. Lupica, and D.M. Lovinger It could be habit forming: drugs of abuse and striatal synaptic plasticity Trends Neurosci. 26 2003 184 192
9. K.E. Hutchison, P.M. Monti, D.J. Rohsenow, R.M. Swift, S.M. Colby, M. Gnys, R.S. Niaura, and A.D. Sirota Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results Psychopharmacology (Berl.) 142 1999 139 143
10. A. Karras, and J.M. Kane Naloxone reduces cigarette smoking Life Sci. 27 1980 1541 1545
11. H.H. Loh, H.C. Liu, A. Cavalli, W. Yang, Y.F. Chen, and L.N. Wei μ-Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality Mol. Brain Res. 54 1998 321 326
12. D.H. Malin, J.R. Lake, V.A. Carter, J.S. Cunningham, K.M. Hebert, D.L. Conrad, and O.B. Wilson The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat Psychopharmacology (Berl.) 115 1994 180 184
13. D.H. Malin, J.R. Lake, V.A. Carter, J.S. Cunningham, and O.B. Wilson Naloxone precipitates nicotine abstinence syndrome in the rat Psychopharmacology (Berl.) 112 1993 339 342
14. D.H. Malin, J.R. Lake, M. Shenoi, T.P. Upchurch, S.C. Johnson, W.E. Schweinle, and C.D. Cadle The nitric oxide synthesis inhibitor nitro-l-arginine (l-NNA) attenuates nicotine abstinence syndrome in the rat Psychopharmacology (Berl.) 140 1998 371 377
15. C. Manzanedo, M.A. Aguilar, M. Rodriguez-Arias, M. Navarro, and J. Minarro 7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine Behav. Brain Res. 150 2004 73 82
16. J.L. Martin, and Y. Itzhak 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion NeuroReport 11 2000 947 949
17. G. Paxinos, and K.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates 2001 Academic Press New York
18. K. Pierzchala, A.A. Houdi, and G.R. Van Loon Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin Peptides 8 1987 1035 1043
19. O.F. Pomerleau Endogenous opioids and smoking: a review of progress and problems Psychoneuroendocrinology 23 1998 115 130
20. J.E. Rose, and W.A. Corrigall Nicotine self-administration in animals and humans: similarities and differences Psychopharmacology (Berl.) 130 1997 28 40
21. I. Shim, H.T. Kim, Y.H. Kim, B.G. Chun, D.H. Hahm, E.H. Lee, S.E. Kim, and H.J. Lee Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat Eur. J. Pharmacol. 443 2002 119 124
22. S.H. Snyder Nitric oxide: first in a new class of neurotransmitters Science 257 1992 494 496
23. U. Tayfun, and I.M.W. Oglesby Nitric oxide and substance dependence Neurosci. Biobehav. Rev. 25 2001 43 52
24. U. Ulusu, I.T. Uzbay, H. Kayir, T. Alici, and S. Karakas Evidence for the role of nitric oxide in nicotine-induced locomotor sensitization in mice Psychopharmacology (Berl.) 2004
25. J.H. Yoo, S.Y. Lee, H.H. Loh, I.K. Ho, and C.G. Jang Loss of nicotine-induced behavioral sensitization in μ-opioid receptor knockout mice Synapse 51 2004 219 223
26. M.R. Zarrindast, A. Gholami, H. Sahraei, and A. Haeri-Rohani Role of nitric oxide in the acquisition and expression of apomorphine- or morphine-induced locomotor sensitisation Eur. J. Pharmacol. 482 2003 205 213